Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.

Journal of child and adolescent psychopharmacology - 1 Jun 2009

Gruber Reut, Joober Ridha, Grizenko Natalie, Leventhal Bennett L, Cook Edwin H, Stein Mark A

Abstract excerpt

The dopamine transporter locus (DAT1) has been studied as a risk factor for attention-deficit/hyperactivity disorder (ADHD) and in pharmacogenetic studies of stimulant response. Several prospective studies have reported an association between the homozygous 9 repeat allele of the DAT1 3' untranslated region (UTR) variable number tandem repeat (VNTR) (DAT1 3') and decreased efficacy of methylphenidate (MPH). We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attention Deficit Disorder with Hyperactivity
Share to Central Nervous System Stimulants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dopamine Plasma Membrane Transport Proteins

Share to Double-Blind Method

Share to Methylphenidate

Share to Pharmacogenetics

Share to Principal Component Analysis

Share to Randomized Controlled Trials as Topic

Source

Open in PubMed Open full text

Identifiers

PMID: 19519258
DOI: 10.1089/cap.2008.0133
PMCID: PMC2856973

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.PMID 19519258Read ↗

Dopamine transporter genotype and methylphenidate dose response in children with ADHD.Semantic proximity Read ↗

DRD4 exon 3 genotype and ADHD: Randomised pharmacodynamic investigation of treatment response to methylphenidate.Semantic proximity Read ↗

Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.Semantic proximity Read ↗

Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Dopamine Transporter and CYP2D6 Gene Relationships with Attention-Deficit/Hyperactivity Disorder Treatment Response in the Methylphenidate and Atomoxetine Crossover Study.Semantic proximity Read ↗

Attention-deficit/hyperactivity disorder pharmacogenomics.Semantic proximity Read ↗

Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHDSemantic proximity Read ↗

Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.Semantic proximity Read ↗

Dopamine transporter genotype influences the physiological response to medication in ADHD.Semantic proximity Read ↗

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Pharmacogenetic Testing for Predicting Methylphenidate Treatment Outcomes in Childhood Attention Deficit Hyperactivity Disorder in Turkey: Focus on Carboxylesterase 1, Latrophilin-3, and Catechol-O-Methyltransferase.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.